<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Albariqi MM</submitter><funding>King Abdulaziz City for Science and Technology (KACST), Saudi Arabia</funding><pagination>e156993</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10104883</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>133(8)</volume><pubmed_abstract>Peripheral neuropathy is a frequent complication of type 2 diabetes mellitus (T2DM). We investigated whether human islet amyloid polypeptide (hIAPP), which forms pathogenic aggregates that damage pancreatic islet β cells in T2DM, is involved in T2DM-associated peripheral neuropathy. In vitro, hIAPP incubation with sensory neurons reduced neurite outgrowth and increased levels of mitochondrial reactive oxygen species. hIAPP-transgenic mice, which have elevated plasma hIAPP levels without hyperglycemia, developed peripheral neuropathy as evidenced by pain-associated behavior and reduced intraepidermal nerve fiber (IENF) density. Similarly, hIAPP Ob/Ob mice, which have hyperglycemia in combination with elevated plasma hIAPP levels, had signs of neuropathy, although more aggravated. In wild-ty</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>Human IAPP is a contributor to painful diabetic peripheral neuropathy.</pubmed_title><pmcid>PMC10104883</pmcid><funding_grant_id>69082/1438/M</funding_grant_id><pubmed_authors>Coert JH</pubmed_authors><pubmed_authors>Prado J</pubmed_authors><pubmed_authors>Versteeg S</pubmed_authors><pubmed_authors>Elenbaas BO</pubmed_authors><pubmed_authors>Eijkelkamp N</pubmed_authors><pubmed_authors>Albariqi MM</pubmed_authors><pubmed_authors>Hack CE</pubmed_authors><pubmed_authors>Hoppener JW</pubmed_authors><pubmed_authors>Brakkee EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human IAPP is a contributor to painful diabetic peripheral neuropathy.</name><description>Peripheral neuropathy is a frequent complication of type 2 diabetes mellitus (T2DM). We investigated whether human islet amyloid polypeptide (hIAPP), which forms pathogenic aggregates that damage pancreatic islet β cells in T2DM, is involved in T2DM-associated peripheral neuropathy. In vitro, hIAPP incubation with sensory neurons reduced neurite outgrowth and increased levels of mitochondrial reactive oxygen species. hIAPP-transgenic mice, which have elevated plasma hIAPP levels without hyperglycemia, developed peripheral neuropathy as evidenced by pain-associated behavior and reduced intraepidermal nerve fiber (IENF) density. Similarly, hIAPP Ob/Ob mice, which have hyperglycemia in combination with elevated plasma hIAPP levels, had signs of neuropathy, although more aggravated. In wild-ty</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-04T22:59:56.401Z</modification><creation>2025-04-04T22:59:56.401Z</creation></dates><accession>S-EPMC10104883</accession><cross_references><pubmed>36917177</pubmed><doi>10.1172/JCI156993</doi></cross_references></HashMap>